Engineers develop nanoparticles that cross the blood-brain barrier

MIT researchers developed drug-carrying nanoparticles that appear to get into the brain more efficiently than drugs given on their own. Using a human tissue model that replicates the blood-brain barrier, they showed the particles could get into tumors and kill glioblastoma cells.

Related Keywords

United Kingdom ,Roger Kamm ,Joelle Straehla ,Paula Hammond ,Jenniferc Johnson ,Foundation For Childhood Cancer Research ,Koch Institute ,National Cancer Institute ,Department Of Chemical Engineering ,Harvard Medical School ,Institute Professor ,Helen Gurley Brown Presidential Initiative ,Cancer Research United Kingdom Brain Tumour Award ,Agreement Award ,Ludwig Center ,Proceedings Of The National Academy Sciences ,Koch Institute For Integrative Cancer Research ,Dana Farber Cancer Institute ,Clinical Investigator ,Integrative Cancer Research ,Dana Farber Cancer ,Cynthia Hajal ,National Academy ,Chemical Engineering ,Ida Green Distinguished Professor ,Mechanical Engineering ,Nature Protocolspaper ,Cooperative Agreement Award ,Horizon Award ,Defense Peer Reviewed Cancer Research Program ,Molecular Oncology Graduate Fellowship ,Rally Foundation ,Childhood Cancer ,Koch Institute Support ,National Cancer ,